Gomez JE - Search Results

1

Treatment Toxicity in Elderly Patients With Advanced Non-Small Cell Lung Cancer.

Kale MS, Mhango G, Gomez JE, Sigel K, Smith CB, Bonomi M, Wisnivesky JP. Kale MS, et al. Among authors: gomez je. Am J Clin Oncol. 2017 Oct;40(5):470-476. doi: 10.1097/COC.0000000000000188. Am J Clin Oncol. 2017. PMID: 25784564 Free PMC article.

2

Targeting lethal minimal residual disease in small cell lung cancer.

Patel JD, Krug LM, Azzoli CG, Gomez J, Kris MG, Miller VA. Patel JD, et al. Semin Oncol. 2003 Feb;30(1):79-85. doi: 10.1053/sonc.2003.50018. Semin Oncol. 2003. PMID: 12635092 Review.

3

Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.

Miller VA, Kris MG, Shah N, Patel J, Azzoli C, Gomez J, Krug LM, Pao W, Rizvi N, Pizzo B, Tyson L, Venkatraman E, Ben-Porat L, Memoli N, Zakowski M, Rusch V, Heelan RT. Miller VA, et al. J Clin Oncol. 2004 Mar 15;22(6):1103-9. doi: 10.1200/JCO.2004.08.158. J Clin Oncol. 2004. PMID: 15020612

4

A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors.

Azzoli CG, Krug LM, Gomez J, Miller VA, Kris MG, Ginsberg MS, Henry R, Jones J, Tyson L, Dunne M, Pizzo B, Farmer A, Venkatraman E, Steffen R, Sirotnak FM. Azzoli CG, et al. Clin Cancer Res. 2007 May 1;13(9):2692-8. doi: 10.1158/1078-0432.CCR-06-1754. Clin Cancer Res. 2007. PMID: 17473201 Clinical Trial.

5

Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer.

Milton DT, Riely GJ, Azzoli CG, Gomez JE, Heelan RT, Kris MG, Krug LM, Pao W, Pizzo B, Rizvi NA, Miller VA. Milton DT, et al. Among authors: gomez je. Cancer. 2007 Aug 1;110(3):599-605. doi: 10.1002/cncr.22816. Cancer. 2007. PMID: 17577220 Free article. Clinical Trial.

6

Efficacy and toxicity of chemoradiotherapy with carboplatin and irinotecan followed by consolidation docetaxel for unresectable stage III non-small cell lung cancer.

Bastos BR, Hatoum GF, Walker GR, Tolba K, Takita C, Gomez J, Santos ES, Lopes G, Raez LE. Bastos BR, et al. J Thorac Oncol. 2010 Apr;5(4):533-9. doi: 10.1097/JTO.0b013e3181ce3e00. J Thorac Oncol. 2010. PMID: 20357618 Free article. Clinical Trial.

7

Prognostic significance of visceral pleural involvement in early-stage lung cancer.

Lakha S, Gomez JE, Flores RM, Wisnivesky JP. Lakha S, et al. Among authors: gomez je. Chest. 2014 Dec;146(6):1619-1626. doi: 10.1378/chest.14-0204. Chest. 2014. PMID: 25032521

8

Cisplatin vs. carboplatin-based chemoradiotherapy in patients >65 years of age with stage III non-small cell lung cancer.

Ezer N, Smith CB, Galsky MD, Mhango G, Gu F, Gomez J, Strauss GM, Wisnivesky J. Ezer N, et al. Radiother Oncol. 2014 Aug;112(2):272-8. doi: 10.1016/j.radonc.2014.07.014. Epub 2014 Aug 20. Radiother Oncol. 2014. PMID: 25150635

9

Dyadic psychosocial intervention for advanced lung cancer patients and their family caregivers: results of a randomized pilot trial.

Badr H, Smith CB, Goldstein NE, Gomez JE, Redd WH. Badr H, et al. Among authors: gomez je. Cancer. 2015 Jan 1;121(1):150-8. doi: 10.1002/cncr.29009. Epub 2014 Sep 10. Cancer. 2015. PMID: 25209975 Free PMC article. Clinical Trial.

10

The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome.

Remark R, Becker C, Gomez JE, Damotte D, Dieu-Nosjean MC, Sautès-Fridman C, Fridman WH, Powell CA, Altorki NK, Merad M, Gnjatic S. Remark R, et al. Among authors: gomez je. Am J Respir Crit Care Med. 2015 Feb 15;191(4):377-90. doi: 10.1164/rccm.201409-1671PP. Am J Respir Crit Care Med. 2015. PMID: 25369536 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters